Hoechst and Rhône-Poulenc Rorer were the two companies that merged to form Aventis. Despite Sanofi-Synthélabo’s size, the company found itself forced to partner with larger pharmaceutical ...

Sanofi India Limited, (Previously known as Aventis Pharma Limited ... fast and effective solution for headaches, which is also gentle on the stomach. A line extension of one of Sanofi Indias ...

The result runs counter to recent data generated with other drugs in the oral SERD category – including a phase 2 trial of Roche's giredestrant and phase 2 and 3 studies of Sanofi's amcenestrant ...

Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

3 Year-23.11%-23.05% 33.40% 35.28% ...

Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 12,867.55 Crore) operating in Pharmaceuticals sector. Sanofi India Ltd. key Products/Revenue Segments ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

After hours: 14 March at 6:37:47 pm GMT-4 Loading Chart for SNY ...